Literature DB >> 16691103

Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.

Albrecht M Kellerer1, Werner Rühm, Linda Walsh.   

Abstract

Risk estimates for radiation-induced cancer are primarily based on the follow-up of the Japanese A-bomb survivors. Their exposures were due to gamma rays and neutrons, and, currently--with the assumed low RBE = 10 of neutrons and reference to the colon dose--the late radiation effects are almost fully attributed to the gamma rays. Solid cancer risk estimates for different organ sites are assessed here, and an inconspicuous but statistically highly significant trend of larger values is found for the organs closer to the body surface; i.e., the organs with less body shielding and, therefore, with larger neutron dose-fractions. Underestimation of the RBE of neutrons can explain this apparent correlation. The trend of ERR/Gy vs. depth ceases to be statistically significant for RBE values close to 100. The suggestion of high RBE values and the corresponding reduction of gamma-ray risk estimates is found to be in line with log-likelihood computations in terms of AMFIT, which provide for the solid cancer mortality of the A-bomb survivors the minimum deviance for RBE = 100 with a 95% confidence lower limit of 25. The present assessment had to use the data made publicly available by RERF. In this form they contain city-, sex-, age-, and dose-categories, but--instead of a separate neutron-dose category--only the mean neutron dose for each data cell. The tentative conclusions that are here obtained should, therefore, be examined by a more definitive analysis, either in terms of grouped data with a separate classification of neutron doses or, ideally, in terms of person by person calculations to be performed at RERF with individually estimated neutron doses.

Entities:  

Mesh:

Year:  2006        PMID: 16691103     DOI: 10.1097/01.HP.0000184917.94232.cd

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  21 in total

1.  Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy.

Authors:  Jonas D Fontenot; Charles Bloch; David Followill; Uwe Titt; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.

Authors:  M S Sasaki; S Endo; Y Ejima; I Saito; K Okamura; Y Oka; M Hoshi
Journal:  Radiat Environ Biophys       Date:  2006-06-29       Impact factor: 1.925

3.  Modeling of cell inactivation and carcinogenesis in the atomic bomb survivors with applications to the mortality from all solid, stomach and liver cancer.

Authors:  Peter Jacob; Linda Walsh; Markus Eidemüller
Journal:  Radiat Environ Biophys       Date:  2008-05-15       Impact factor: 1.925

4.  Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.

Authors:  Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2012-11-17       Impact factor: 1.925

5.  The influence of follow-up on DS02 low-dose ranges with a significant excess relative risk of all solid cancer in the Japanese A-bomb survivors.

Authors:  Linda Walsh; Uwe Schneider
Journal:  Radiat Environ Biophys       Date:  2016-09-01       Impact factor: 1.925

Review 6.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

7.  Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.

Authors:  Rui Zhang; Rebecca M Howell; Annelise Giebeler; Phillip J Taddei; Anita Mahajan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2013-01-16       Impact factor: 3.609

8.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

9.  Biological effects of high-energy neutrons measured in vivo using a vertebrate model.

Authors:  Wendy W Kuhne; Brad B Gersey; Richard Wilkins; Honglu Wu; Stephen A Wender; Varghese George; William S Dynan
Journal:  Radiat Res       Date:  2009-10       Impact factor: 2.841

10.  Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.